Advanced Medical Solutions Grp PLC Pre-Close Trading Update (5747R)
June 30 2015 - 2:00AM
UK Regulatory
TIDMAMS
RNS Number : 5747R
Advanced Medical Solutions Grp PLC
30 June 2015
30 June 2015
Advanced Medical Solutions Group plc
("AMS" or the "Group")
Pre-Close Trading Update
Winsford, UK, 30 June 2015 - Advanced Medical Solutions Group
plc (AIM: AMS.L), the surgical and advanced woundcare specialist
company, today announces an update on trading prior to its close
period for the half year ended 30 June 2015.
The Board confirms that trading for the half year is in line
with the Board's expectations and currently expects both revenue
and profitability for the full year 2015 to be in line with present
market expectations.
Chris Meredith, Chief Executive Officer of AMS, commented: "The
Board is pleased with the ongoing good performance of the business.
We continue to gain market share with our high quality products by
delivering innovation to patients and surgeons."
- Ends -
For further information, please visit www.admedsol.com or
contact:
Advanced Medical Solutions Group plc
Chris Meredith, Chief Executive Officer
Mary Tavener, Group Finance Director +44 (0) 1606 545508
Consilium Strategic Communications +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys AMS@consilium-comms.com
Investec Bank PLC (NOMAD & Broker)
Gary Clarence / Daniel Adams / Patrick Robb +44 (0) 20 7597 5970
About Advanced Medical Solutions Group plc - see
www.admedsol.com
AMS is a world-leading independent developer and manufacturer of
innovative and technologically advanced products for the global
surgical, wound care and wound closure markets, focused on quality
outcomes for patients and value for payors. AMS has a wide range of
products that include silver alginates, alginates, foams, tissue
adhesives, sutures and haemostats, which it markets under its
brands ActivHeal(R) , LiquiBand(R) and RESORBA(R) as well as
supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in
the Netherlands, two in Germany and one in the Czech Republic, are
sold in 65 countries via a network of multinational or regional
partners and distributors, as well as via AMS's own direct sales
forces in the UK, Germany, the Czech Republic and Russia.
Established in 1991, the Group has approximately 470 employees. For
more information please see www.admedsol.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTLLFERRVIAFIE
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Advanced Medical Solutions (LSE:AMS)
Historical Stock Chart
From Apr 2023 to Apr 2024